Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: An international task force consensus statement

Circulation

Volumn 132, Issue 5, 2015, Pages 441-453

  Corrado, Domenico ^a   Wichter, Thomas ^b   Link, Mark S ^c   Hauer, Richard N W ^d   Marchlinski, Frank E ^e   Anastasakis, Aris ^f   Bauce, Barbara ^a   Basso, Cristina ^a   Brunckhorst, Corinna ^g   Tsatsopoulou, Adalena ^h   Tandri, Harikrishna ⁱ   Paul, Matthias ^j   Schmied, Christian ^g   Pelliccia, Antonio ^k   Duru, Firat ^g   Protonotarios, Nikos ^h   Estes, NA Mark ^c   Mckenna, William J ^l   Thiene, Gaetano ^a   Marcus, Frank I ^m   Calkins, Hugh ⁱ   more..

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b MarienHospital Osnabruck   (Germany)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^g UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^h Yannis Protonotarios Medical Centre   (Greece)

ⁱ JOHNS HOPKINS HOSPITAL   (United States)

^j UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^k Center of Sports Sciences   (Italy)

^l UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^m UNIVERSITY OF ARIZONA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; CATHETER ABLATION; CONSENSUS; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART PRELOAD; HEART RIGHT VENTRICLE DYSPLASIA; HEART TRANSPLANTATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LIFESTYLE MODIFICATION; MEDICAL DEVICE COMPLICATION; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT INDICATION; ADVISORY COMMITTEE; ALGORITHM; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CONSENSUS DEVELOPMENT; ELECTROCARDIOGRAPHY; INTERNATIONAL COOPERATION; RISK FACTOR;

ADRENERGIC BETA-ANTAGONISTS; ADVISORY COMMITTEES; ALGORITHMS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CATHETER ABLATION; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; HEART TRANSPLANTATION; HUMANS; INTERNATIONAL AGENCIES; RISK FACTORS;

EID: 84939560535     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.017944     Document Type: Article

References (92)

1. Marcus FI, Fontaine GH, Guiraudon G, Frank R, Laurenceau JL, Malergue C, Grosgogeat Y, Right ventricular dysplasia: a report of 24 adult cases. Circulation 1982 65 384 398
2. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N, Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988 318 129 133. doi: 10.1056/NEJM198801213180301
3. Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M, Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation 1996 94 983 991
4. Corrado D, Basso C, Thiene G, McKenna WJ, Davies MJ, Fontaliran F, Nava A, Silvestri F, Blomstrom-Lundqvist C, Wlodarska EK, Fontaine G, Camerini F, Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol 1997 30 1512 1520
5. Corrado D, Basso C, Thiene G, Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment. Heart 2000 83 588 595
6. Sen-Chowdhry S, Lowe MD, Sporton SC, McKenna WJ, Arrhythmogenic right ventricular cardiomyopathy: clinical presentation, diagnosis, and management. Am J Med 2004 117 685 695. doi: 10.1016/j.amjmed.2004.04.028
7. Dalal D, Nasir K, Bomma C, Prakasa K, Tandri H, Piccini J, Roguin A, Tichnell C, James C, Russell SD, Judge DP, Abraham T, Spevak PJ, Bluemke DA, Calkins H, Arrhythmogenic right ventricular dysplasia: a United States experience. Circulation 2005 112 3823 3832. doi: 10.1161/CIRCULATIONAHA.105.542266
8. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G, Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006 296 1593 1601. doi: 10.1001/jama.296.13.1593
9. Sen-Chowdhry S, Prasad SK, Syrris P, Wage R, Ward D, Merrifield R, Smith GC, Firmin DN, Pennell DJ, McKenna WJ, Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. J Am Coll Cardiol 2006 48 2132 2140. doi: 10.1016/j.jacc.2006.07.045
10. Basso C, Corrado D, Marcus FI, Nava A, Thiene G, Arrhythmogenic right ventricular cardiomyopathy. Lancet 2009 373 1289 1300. doi: 10.1016/S0140-6736(09)60256-7
11. Corrado D, Basso C, Leoni L, Tokajuk B, Turrini P, Bauce B, Migliore F, Pavei A, Tarantini G, Napodano M, Ramondo A, Buja G, Iliceto S, Thiene G, Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia. J Am Coll Cardiol 2008 51 731 739. doi: 10.1016/j.jacc.2007.11.027
12. Herren T, Gerber PA, Duru F, Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a not so rare "disease of the desmosome" with multiple clinical presentations. Clin Res Cardiol 2009 98 141 158. doi: 10.1007/s00392-009-0751-4
13. Patel HC, Calkins H, Arrhythmogenic right ventricular dysplasia. Curr Treat Options Cardiovasc Med 2010 12 598 613. doi: 10.1007/s11936-010-0097-2
14. Sen-Chowdhry S, Morgan RD, Chambers JC, McKenna WJ, Arrhythmogenic cardiomyopathy: etiology, diagnosis, and treatment. Annu Rev Med 2010 61 233 253. doi: 10.1146/annurev.med.052208.130419
15. Basso C, Corrado D, Bauce B, Thiene G, Arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol 2012 5 1233 1246. doi: 10.1161/CIRCEP.111.962035
16. Paul M, Wichter T, Fabritz L, Waltenberger J, Schulze-Bahr E, Kirchhof P, Arrhythmogenic right ventricular cardiomyopathy: an update on pathophysiology, genetics, diagnosis, and risk stratification. Herzschrittmacherther Elektrophysiol 2012 23 186 195. doi: 10.1007/s00399-012-0233-7
17. Calkins H, Arrhythmogenic right ventricular dysplasia. Curr Probl Cardiol 2013 38 103 123. doi: 10.1016/j.cpcardiol.2012.12.002
18. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G, Camerini F, Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994 71 215 218
19. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, Calkins H, Corrado D, Cox MG, Daubert JP, Fontaine G, Gear K, Hauer R, Nava A, Picard MH, Protonotarios N, Saffitz JE, Sanborn DM, Steinberg JS, Tandri H, Thiene G, Towbin JA, Tsatsopoulou A, Wichter T, Zareba W, Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 2010 121 1533 1541. doi: 10.1161/CIRCULATIONAHA.108.840827
20. Nava A, Bauce B, Basso C, Muriago M, Rampazzo A, Villanova C, Daliento L, Buja G, Corrado D, Danieli GA, Thiene G, Clinical profile and long-Term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2000 36 2226 2233
21. Lemola K, Brunckhorst C, Helfenstein U, Oechslin E, Jenni R, Duru F, Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: long term experience of a tertiary care centre. Heart 2005 91 1167 1172. doi: 10.1136/hrt.2004.038620
22. Corrado D, Leoni L, Link MS, Della Bella P, Gaita F, Curnis A, Salerno JU, Igidbashian D, Raviele A, Disertori M, Zanotto G, Verlato R, Vergara G, Delise P, Turrini P, Basso C, Naccarella F, Maddalena F, Estes NA 3rd, Buja G, Thiene G, Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2003 108 3084 3091. doi: 10.1161/01.CIR.0000103130.33451.D2
23. Link MS, Laidlaw D, Polonsky B, Zareba W, McNitt S, Gear K, Marcus F, Estes NA 3rd, Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment. J Am Coll Cardiol 2014 64 119 125. doi: 10.1016/j.jacc.2014.04.035
24. Watkins DA, Hendricks N, Shaboodien G, Mbele M, Parker M, Vezi BZ, Latib A, Chin A, Little F, Badri M, Moolman-Smook JC, Okreglicki A, Mayosi BM, ARVC Registry of the Cardiac Arrhythmia Society of Southern Africa (CASSA) Clinical features, survival experience, and profile of plakophylin-2 gene mutations in participants of the arrhythmogenic right ventricular cardiomyopathy registry of South Africa. Heart Rhythm 2009 6 11 Suppl S10 S17. doi: 10.1016/j.hrthm.2009.08.018
25. Corrado D, Calkins H, Link MS, Leoni L, Favale S, Bevilacqua M, Basso C, Ward D, Boriani G, Ricci R, Piccini JP, Dalal D, Santini M, Buja G, Iliceto S, Estes NA 3rd, Wichter T, McKenna WJ, Thiene G, Marcus FI, Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation 2010 122 1144 1152. doi: 10.1161/CIRCULATIONAHA.109.913871
26. Bhonsale A, James CA, Tichnell C, Murray B, Gagarin D, Philips B, Dalal D, Tedford R, Russell SD, Abraham T, Tandri H, Judge DP, Calkins H, Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention. J Am Coll Cardiol 2011 58 1485 1496. doi: 10.1016/j.jacc.2011.06.043
27. Hulot JS, Jouven X, Empana JP, Frank R, Fontaine G, Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 2004 110 1879 1884. doi: 10.1161/01.CIR.0000143375.93288.82
28. Wichter T, Paul M, Wollmann C, Acil T, Gerdes P, Ashraf O, Tjan TD, Soeparwata R, Block M, Borggrefe M, Scheld HH, Breithardt G, Böcker D, Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-Term follow-up and complications in 60 patients. Circulation 2004 109 1503 1508. doi: 10.1161/01.CIR.0000121738.88273.43
29. Saguner AM, Vecchiati A, Baldinger SH, Rüeger S, Medeiros-Domingo A, Mueller-Burri AS, Haegeli LM, Biaggi P, Manka R, Lüscher TF, Fontaine G, Delacrétaz E, Jenni R, Held L, Brunckhorst C, Duru F, Tanner FC, Different prognostic value of functional right ventricular parameters in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circ Cardiovasc Imaging 2014 7 230 239. doi: 10.1161/CIRCIMAGING.113.000210
30. Pinamonti B, Dragos AM, Pyxaras SA, Merlo M, Pivetta A, Barbati G, Di Lenarda A, Morgera T, Mestroni L, Sinagra G, Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry. Eur Heart J 2011 32 1105 1113. doi: 10.1093/eurheartj/ehr040
31. Bhonsale A, James CA, Tichnell C, Murray B, Madhavan S, Philips B, Russell SD, Abraham T, Tandri H, Judge DP, Calkins H, Risk stratification in arrhythmogenic right ventricular dysplasia/cardiomyopathy-Associated desmosomal mutation carriers. Circ Arrhythm Electrophysiol 2013 6 569 578. doi: 10.1161/CIRCEP.113.000233
32. Rigato I, Bauce B, Rampazzo A, Zorzi A, Pilichou K, Mazzotti E, Migliore F, Marra MP, Lorenzon A, De Bortoli M, Calore M, Nava A, Daliento L, Gregori D, Iliceto S, Thiene G, Basso C, Corrado D, Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy. Circ Cardiovasc Genet 2013 6 533 542. doi: 10.1161/CIRCGENETICS.113.000288
33. Saguner AM, Medeiros-Domingo A, Schwyzer MA, On CJ, Haegeli LM, Wolber T, Hürlimann D, Steffel J, Krasniqi N, Rüeger S, Held L, Lüscher TF, Brunckhorst C, Duru F, Usefulness of inducible ventricular tachycardia to predict long-Term adverse outcomes in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol 2013 111 250 257. doi: 10.1016/j.amjcard.2012.09.025
34. Migliore F, Zorzi A, Silvano M, Bevilacqua M, Leoni L, Marra MP, Elmaghawry M, Brugnaro L, Dal Lin C, Bauce B, Rigato I, Tarantini G, Basso C, Buja G, Thiene G, Iliceto S, Corrado D, Prognostic value of endocardial voltage mapping in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circ Arrhythm Electrophysiol 2013 6 167 176. doi: 10.1161/CIRCEP.111.974881
35. Santangeli P, Dello Russo A, Pieroni M, Casella M, Di Biase L, Burkhardt JD, Sanchez J, Lakkireddy D, Carbucicchio C, Zucchetti M, Pelargonio G, Themistoclakis S, Camporeale A, Rossillo A, Beheiry S, Hongo R, Bellocci F, Tondo C, Natale A, Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: results from a prospective risk stratification study. Heart Rhythm 2012 9 1200 1206. doi: 10.1016/j.hrthm.2012.03.057
36. Saguner AM, Ganahl S, Baldinger SH, Kraus A, Medeiros-Domingo A, Nordbeck S, Saguner AR, Mueller-Burri AS, Haegeli LM, Wolber T, Steffel J, Krasniqi N, Delacrétaz E, Lüscher TF, Held L, Brunckhorst CB, Duru F, Usefulness of electrocardiographic parameters for risk prediction in arrhythmogenic right ventricular dysplasia. Am J Cardiol 2014 113 1728 1734. doi: 10.1016/j.amjcard.2014.02.031
37. Blomström-Lundqvist C, Sabel KG, Olsson SB, A long term follow up of 15 patients with arrhythmogenic right ventricular dysplasia. Br Heart J 1987 58 477 488
38. Marcus FI, Fontaine GH, Frank R, Gallagher JJ, Reiter MJ, Long-Term follow-up in patients with arrhythmogenic right ventricular disease. Eur Heart J 1989 10 Suppl D 68 73
39. Peters S, Long-Term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres. J Cardiovasc Med (Hagerstown) 2007 8 521 526. doi: 10.2459/01.JCM.0000278450.35107.b3
40. Corrado D, Thiene G, Nava A, Rossi L, Pennelli N, Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. Am J Med 1990 89 588 596
41. Wichter T, Borggrefe M, Haverkamp W, Chen X, Breithardt G, Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation 1992 86 29 37
42. Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G, Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 2003 42 1959 1963
43. Corrado D, Schmied C, Basso C, Borjesson M, Schiavon M, Pelliccia A, Vanhees L, Thiene G, Risk of sports: do we need a pre-participation screening for competitive and leisure athletes? Eur Heart J 2011 32 934 944. doi: 10.1093/eurheartj/ehq482
44. Kirchhof P, Fabritz L, Zwiener M, Witt H, Schäfers M, Zellerhoff S, Paul M, Athai T, Hiller KH, Baba HA, Breithardt G, Ruiz P, Wichter T, Levkau B, Age-And training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation 2006 114 1799 1806. doi: 10.1161/CIRCULATIONAHA.106.624502
45. Corrado D, Thiene G, Arrhythmogenic right ventricular cardiomyopathy/dysplasia: clinical impact of molecular genetic studies. Circulation 2006 113 1634 1637. doi: 10.1161/CIRCULATIONAHA.105.616490
46. Sen-Chowdhry S, Syrris P, McKenna WJ, Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2007 50 1813 1821. doi: 10.1016/j.jacc.2007.08.008
47. James CA, Bhonsale A, Tichnell C, Murray B, Russell SD, Tandri H, Tedford RJ, Judge DP, Calkins H, Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-Associated desmosomal mutation carriers. J Am Coll Cardiol 2013 62 1290 1297. doi: 10.1016/j.jacc.2013.06.033
48. Saberniak J, Hasselberg NE, Borgquist R, Platonov PG, Sarvari SI, Smith HJ, Ribe M, Holst AG, Edvardsen T, Haugaa KH, Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members. Eur J Heart Fail 2014 16 1337 1344. doi: 10.1002/ejhf.181
49. Marcus GM, Glidden DV, Polonsky B, Zareba W, Smith LM, Cannom DS, Estes NA 3rd, Marcus F, Scheinman MM, Multidisciplinary Study of Right Ventricular Dysplasia Investigators Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. J Am Coll Cardiol 2009 54 609 615. doi: 10.1016/j.jacc.2009.04.052
50. Wichter T, Hindricks G, Lerch H, Bartenstein P, Borggrefe M, Schober O, Breithardt G, Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy. An analysis using 123I-meta-iodobenzylguanidine scintigraphy. Circulation 1994 89 667 683
51. Wichter T, Schäfers M, Rhodes CG, Borggrefe M, Lerch H, Lammertsma AA, Hermansen F, Schober O, Breithardt G, Camici PG, Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy: quantitative assessment of presynaptic norepinephrine reuptake and postsynaptic beta-Adrenergic receptor density with positron emission tomography. Circulation 2000 101 1552 1558
52. Fabritz L, Fortmüller L, Yu TY, Paul M, Kirchhof P, Can preload-reducing therapy prevent disease progression in arrhythmogenic right ventricular cardiomyopathy? Experimental evidence and concept for a clinical trial. Prog Biophys Mol Biol 2012 110 340 346. doi: 10.1016/j.pbiomolbio.2012.08.010
53. Fabritz L, Hoogendijk MG, Scicluna BP, van Amersfoorth SC, Fortmueller L, Wolf S, Laakmann S, Kreienkamp N, Piccini I, Breithardt G, Noppinger PR, Witt H, Ebnet K, Wichter T, Levkau B, Franke WW, Pieperhoff S, de Bakker JM, Coronel R, Kirchhof P, Load-reducing therapy prevents development of arrhythmogenic right ventricular cardiomyopathy in plakoglobin-deficient mice. J Am Coll Cardiol 2011 57 740 750. doi: 10.1016/j.jacc.2010.09.046
54. Bauce B, Basso C, Rampazzo A, Beffagna G, Daliento L, Frigo G, Malacrida S, Settimo L, Danieli G, Thiene G, Nava A, Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. Eur Heart J 2005 26 1666 1675. doi: 10.1093/eurheartj/ehi341
55. Sen-Chowdhry S, Syrris P, Ward D, Asimaki A, Sevdalis E, McKenna WJ, Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation 2007 115 1710 1720. doi: 10.1161/CIRCULATIONAHA.106.660241
56. Sen-Chowdhry S, Syrris P, Prasad SK, Hughes SE, Merrifield R, Ward D, Pennell DJ, McKenna WJ, Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol 2008 52 2175 2187. doi: 10.1016/j.jacc.2008.09.019
57. Marra MP, Leoni L, Bauce B, Corbetti F, Zorzi A, Migliore F, Silvano M, Rigato I, Tona F, Tarantini G, Cacciavillani L, Basso C, Buja G, Thiene G, Iliceto S, Corrado D, Imaging study of ventricular scar in arrhythmogenic right ventricular cardiomyopathy: comparison of 3D standard electroanatomical voltage mapping and contrast-enhanced cardiac magnetic resonance. Circ Arrhythm Electrophysiol 2012 5 91 100. doi: 10.1161/CIRCEP.111.964635
58. te Riele AS, Bhonsale A, James CA, Rastegar N, Murray B, Burt JR, Tichnell C, Madhavan S, Judge DP, Bluemke DA, Zimmerman SL, Kamel IR, Calkins H, Tandri H, Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-Associated desmosomal mutation carriers. J Am Coll Cardiol 2013 62 1761 1769. doi: 10.1016/j.jacc.2012.11.087
59. Wlodarska EK, Wozniak O, Konka M, Rydlewska-Sadowska W, Biederman A, Hoffman P, Thromboembolic complications in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Europace 2006 8 596 600. doi: 10.1093/europace/eul053
60. Fontaine G, Frank R, Rougier I, Tonet JL, Gallais Y, Farenq G, Lascault G, Lilamand M, Fontaliran F, Chomette G, Electrode catheter ablation of resistant ventricular tachycardia in arrhythmogenic right ventricular dysplasia: experience of 13 patients with a mean follow-up of 45 months. Eur Heart J 1989 10 Suppl D 74 81
61. Ellison KE, Friedman PL, Ganz LI, Stevenson WG, Entrainment mapping and radiofrequency catheter ablation of ventricular tachycardia in right ventricular dysplasia. J Am Coll Cardiol 1998 32 724 728
62. Fontaine G, Tonet J, Gallais Y, Lascault G, Hidden-Lucet F, Aouate P, Halimi F, Poulain F, Johnson N, Charfeddine H, Frank R, Ventricular tachycardia catheter ablation in arrhythmogenic right ventricular dysplasia: a 16-year experience. Curr Cardiol Rep 2000 2 498 506
63. Reithmann C, Hahnefeld A, Remp T, Dorwarth U, Dugas M, Steinbeck G, Hoffmann E, Electroanatomic mapping of endocardial right ventricular activation as a guide for catheter ablation in patients with arrhythmogenic right ventricular dysplasia. Pacing Clin Electrophysiol 2003 26 1308 1316
64. Marchlinski FE, Zado E, Dixit S, Gerstenfeld E, Callans DJ, Hsia H, Lin D, Nayak H, Russo A, Pulliam W, Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy. Circulation 2004 110 2293 2298. doi: 10.1161/01.CIR.0000145154.02436.90
65. Miljoen H, State S, de Chillou C, Magnin-Poull I, Dotto P, Andronache M, Abdelaal A, Aliot E, Electroanatomic mapping characteristics of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Europace 2005 7 516 524. doi: 10.1016/j.eupc.2005.07.004
66. Verma A, Kilicaslan F, Schweikert RA, Tomassoni G, Rossillo A, Marrouche NF, Ozduran V, Wazni OM, Elayi SC, Saenz LC, Minor S, Cummings JE, Burkhardt JD, Hao S, Beheiry S, Tchou PJ, Natale A, Short-And long-Term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. Circulation 2005 111 3209 3216. doi: 10.1161/CIRCULATIONAHA.104.510503
67. Satomi K, Kurita T, Suyama K, Noda T, Okamura H, Otomo K, Shimizu W, Aihara N, Kamakura S, Catheter ablation of stable and unstable ventricular tachycardias in patients with arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol 2006 17 469 476. doi: 10.1111/j.1540-8167.2006.00434.x
68. Dalal D, Jain R, Tandri H, Dong J, Eid SM, Prakasa K, Tichnell C, James C, Abraham T, Russell SD, Sinha S, Judge DP, Bluemke DA, Marine JE, Calkins H, Long-Term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2007 50 432 440. doi: 10.1016/j.jacc.2007.03.049
69. Nogami A, Sugiyasu A, Tada H, Kurosaki K, Sakamaki M, Kowase S, Oginosawa Y, Kubota S, Usui T, Naito S, Changes in the isolated delayed component as an endpoint of catheter ablation in arrhythmogenic right ventricular cardiomyopathy: predictor for long-Term success. J Cardiovasc Electrophysiol 2008 19 681 688. doi: 10.1111/j.1540-8167.2008.01104.x
70. Garcia FC, Bazan V, Zado ES, Ren JF, Marchlinski FE, Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2009 120 366 375. doi: 10.1161/CIRCULATIONAHA.108.834903
71. Berruezo A, Fernández-Armenta J, Mont L, Zeljko H, Andreu D, Herczku C, Boussy T, Tolosana JM, Arbelo E, Brugada J, Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique. Circ Arrhythm Electrophysiol 2012 5 111 121. doi: 10.1161/CIRCEP.110.960740
72. Philips B, Madhavan S, James C, Tichnell C, Murray B, Dalal D, Bhonsale A, Nazarian S, Judge DP, Russell SD, Abraham T, Calkins H, Tandri H, Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Arrhythm Electrophysiol 2012 5 499 505. doi: 10.1161/CIRCEP.111.968677
73. Tschabrunn CM, Marchlinski FE, Ventricular tachycardia mapping and ablation in arrhythmogenic right ventricular cardiomyopathy/dysplasia: Lessons Learned. World J Cardiol 2014 6 959 967. doi: 10.4330/wjc.v6.i9.959
74. Boriani G, Artale P, Biffi M, Martignani C, Frabetti L, Valzania C, Diemberger I, Ziacchi M, Bertini M, Rapezzi C, Parlapiano M, Branzi A, Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Vessels 2007 22 184 192. doi: 10.1007/s00380-006-0963-8
75. Breithardt G, Wichter T, Haverkamp W, Borggrefe M, Block M, Hammel D, Scheld HH, Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease. Am Heart J 1994 127 4 Pt 2 1151 1158
76. Hodgkinson KA, Parfrey PS, Bassett AS, Kupprion C, Drenckhahn J, Norman MW, Thierfelder L, Stuckless SN, Dicks EL, McKenna WJ, Connors SP, The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). J Am Coll Cardiol 2005 45 400 408. doi: 10.1016/j.jacc.2004.08.068
77. Link MS, Wang PJ, Haugh CJ, Homoud MK, Foote CB, Costeas XB, Estes NA 3rd, Arrhythmogenic right ventricular dysplasia: clinical results with implantable cardioverter defibrillators. J Interv Card Electrophysiol 1997 1 41 48
78. Piccini JP, Dalal D, Roguin A, Bomma C, Cheng A, Prakasa K, Dong J, Tichnell C, James C, Russell S, Crosson J, Berger RD, Marine JE, Tomaselli G, Calkins H, Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm 2005 2 1188 1194. doi: 10.1016/j.hrthm.2005.08.022
79. Roguin A, Bomma CS, Nasir K, Tandri H, Tichnell C, James C, Rutberg J, Crosson J, Spevak PJ, Berger RD, Halperin HR, Calkins H, Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2004 43 1843 1852. doi: 10.1016/j.jacc.2004.01.030
80. Schuler PK, Haegeli LM, Saguner AM, Wolber T, Tanner FC, Jenni R, Corti N, Lüscher TF, Brunckhorst C, Duru F, Predictors of appropriate ICD therapy in patients with arrhythmogenic right ventricular cardiomyopathy: long term experience of a tertiary care center. PLoS One 2012 7 e39584. doi: 10.1371/journal.pone.0039584
81. Tavernier R, Gevaert S, De Sutter J, De Clercq A, Rottiers H, Jordaens L, Fonteyne W, Long term results of cardioverter-defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias. Heart 2001 85 53 56
82. Schinkel AF, Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications. Circ Arrhythm Electrophysiol 2013 6 562 568. doi: 10.1161/CIRCEP.113.000392
83. Ingles J, Sarina T, Kasparian N, Semsarian C, Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease. Int J Cardiol 2013 168 3779 3784. doi: 10.1016/j.ijcard.2013.06.006
84. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA 3rd, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W, MADIT-RIT Trial Investigators Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012 367 2275 2283. doi: 10.1056/NEJMoa1211107
85. Marcus F, Basso C, Gear K, Sorrell VL, Pitfalls in the diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Am J Cardiol 2010 105 1036 1039. doi: 10.1016/j.amjcard.2009.11.033
86. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJV, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WHW, Tsai EJ, Wilkoff BL, 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013 128 e240 e327
87. Dubin AM, Feinstein JA, Reddy VM, Hanley FL, Van Hare GF, Rosenthal DN, Electrical resynchronization: a novel therapy for the failing right ventricle. Circulation 2003 107 2287 2289. doi: 10.1161/01.CIR.0000070930.33499.9F
88. Tedford RJ, James C, Judge DP, Tichnell C, Murray B, Bhonsale A, Philips B, Abraham T, Dalal D, Halushka MK, Tandri H, Calkins H, Russell SD, Cardiac transplantation in arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2012 59 289 290. doi: 10.1016/j.jacc.2011.09.051
89. Chachques JC, Argyriadis PG, Fontaine G, Hebert JL, Frank RA, D'Attellis N, Fabiani JN, Carpentier AF, Right ventricular cardiomyoplasty: 10-year follow-up. Ann Thorac Surg 2003 75 1464 1468
90. Zacharias J, Forty J, Doig JC, Bourke JP, Hilton CJ, Right ventricular disarticulation. An 18-year single centre experience. Eur J Cardiothorac Surg 2005 27 1000 1004. doi: 10.1016/j.ejcts.2005.02.020
91. Bakir I, Brugada P, Sarkozy A, Vandepitte C, Wellens F, A novel treatment strategy for therapy refractory ventricular arrhythmias in the setting of arrhythmogenic right ventricular dysplasia. Europace 2007 9 267 269. doi: 10.1093/europace/eum029
92. Coleman MA, Bos JM, Johnson JN, Owen HJ, Deschamps C, Moir C, Ackerman MJ, Videoscopic left cardiac sympathetic denervation for patients with recurrent ventricular fibrillation/malignant ventricular arrhythmia syndromes besides congenital long-QT syndrome. Circ Arrhythm Electrophysiol 2012 5 782 788. doi: 10.1161/CIRCEP.112.971754